|Articles|June 30, 2011
Should Pharma Invest in R&D or Search for External Drug Candidates?
Find out how pharma can find new drug candidates and refill the pipeline in this episode of Pharma Faceoff. Watch now.
Advertisement
Should Pharma Invest in R&D or Search for External Drug Candidates?
Join Shire's Renee Cohen, Sanofi's Ray Jupp, Deutsche Bank's Barbara Ryan, Ken Kaitin of Tufts University and Charlotte Sibley as they debate how pharma can find new drug candidates and refill the pipeline in this episode of Pharma Faceoff
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
4
Developing New Therapies Across Multiple Regulatory Landscapes
5